Targeting the Nucleotide Metabolism Proteins of the NUDIX Family and SAMHD1 in Cancer

Archive ouverte

Forey, Prescillia | Cros-Perrial, Emeline | Dumontet, Charles | Jordheim, Lars Petter

Edité par CCSD ; Bentham Science Publishers -

International audience. Nucleotide metabolism has been targeted for many years and in various clinical settings, including cancer. The increased knowledge of certain enzymes involved in this metabolism and associated cellular processes accumulated over the last few years, gives important information related to the druggability of certain proteins and the use of inhibitors for others. Here, we review recent data on such enzymes with a major interest in drug development, i.e. SAMHD1 and the proteins of the NUDIX family. These include information on their roles in cancer progression, correlations with clinical outcomes in cancer patients, and the development and study of enzymatic inhibitors.

Consulter en ligne

Suggestions

Du même auteur

Transcriptional and Metabolic Investigation in 5′-Nucleotidase Deficient Cancer Cell Lines

Archive ouverte | Cadassou, Octavia | CCSD

International audience. Enzymes of nucleoside and nucleotide metabolism regulate important cellular processes with potential impacts on nucleotide-unrelated parameters. We have used a set of CRISPR/Cas9-modified cel...

The synergy between alkylating agents and ERCC1–XPF inhibitors is p53 dependent

Archive ouverte | Ciniero, Gloria | CCSD

International audience. Abstract Background DNA repair plays a major role in maintaining genomic stability, thus limiting the transformation of normal cells into cancer cells. However, in cancer patients treated wit...

SLX4 and XPF are involved in cell migration and EMT in a cell-specific manner

Archive ouverte | Cros-Perrial, Emeline | CCSD

International audience

Chargement des enrichissements...